IDEAL MAILING LIST
Sign up for information on the next Ideal^® Experience click here

The IDEAL^® Virtual Learning Center is a certified CME expert-guided interactive learning experience that provides a scientific presentation consisting of relevant evidence-based disease management information coupled with virtual teaching rounds.

During the Virtual Gallery, you will be asked to answer questions regarding the scientific presentations. This curriculum is designed to provide physicians and nurse professionals an opportunity to improve the diagnosis and management of patients presenting with androgen deficiency.

There are 2 corresponding activities in this CME curriculum. To participate, you must register at this site. Registration and participation are both available at no charge. Once you are registered, log in using the link titled Login or Register on the right to enter and select the Curriculum page to begin the program.

LAST REVIEW DATE: October 2013
ACTIVITY RELEASE/EXPIRATION DATES: October 2013 through October 2014
ESTIMATED TIME TO COMPLETE EACH PART OF THIS ACTIVITY:  Virtual Education Gallery 15-20 minutes and Virtual Teaching Rounds 20-25 minutes. This program must be completed in its entirety. This enduring material has been approved for a maximum of 1.0 AMA PRA Category 1 Credit™.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation. The Endocrine Society designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Upon completion of this activity, participants will be better able to:

• Evaluate the signs and symptoms of androgen deficiency according to evidence-based guidelines
• Discuss the risks and benefits of testosterone replacement therapy more effectively with your patients
• Initiate an ongoing treatment plan that optimizes outcomes in men with androgen deficiency
• Describe the clinical factors in men with androgen deficiency that indicate further evaluation may be necessary

This continuing medical education activity should be of substantial interest to endocrinologists, clinical researchers, and other endocrine professionals.

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, The Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Special Programs Committee of The Endocrine Society. The commercial supporters of this activity have no influence over the planning of this CME activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to The Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

• Shalender Bhasin, MD:
• Research grant support, Abbott Laboratories.
• Glenn Cunningham, MD:
• Consultant, Abbott Laboratories, Clarus Therapeutics, Endo Pharmaceuticals, Repros: Speaker, Endo Pharmaceuticals
• Alvin Matsumoto, MD:
• Consultant, Clarus therapeutics, Endo Pharmaceuticals, Ferring Pharmaceuticals, Repros Therapeutics. Advisory panel and research support, Abbott Laboratories. Speaker for Merck & Co., Inc.

Endocrine Society staff and Educational Awareness Solutions staff associated with the development of content for this activity reported no relevant financial relationships.

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of The Endocrine Society.

Use of professional judgment:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindication

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such off-label use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Virtual Learning Center, Maintaining the Pace in Androgen Deficiency provides physicians and nurse professionals an opportunity to enhance their competence and performance in improving the diagnosis and management of Hypogonadism.

Virtual Education Gallery

Virtual Education Gallery consists of a series of stylized scientific panels synchronized with audio commentary that addresses material to support the educational objectives of this CME activity. During the Virtual Education Gallery, participants will answer questions regarding the scientific presentation. The questions are designed to assess current practice skills. The Virtual Education Gallery will take approximately 15-20 minutes to complete.

Virtual Teaching Rounds

The Virtual Teaching Rounds begin with the participant being introduced to the patient and presented with relevant clinical information. The participant will review the patient's history and view highlights of the patient's exam, discussion of potential therapeutic options, patient compliance, and possible risk mitigation strategies. The participant will be presented with various decision points through multiple choice answers and must make diagnostic and therapeutic decisions by selecting the options(s) he or she feels is "Recommended." Expert feedback is provided for each option, including the "Optional" and "Not Recommended" options. Following each Decision Point, the case presentation continues. During and after the patient encounter, the expert(s) provide a commentary that encapsulates the management methods used and provides the expert's treatment rationale.

At the conclusion of the Virtual Teaching Rounds, the learner will complete an activity evaluation and receive credit. The Virtual Teaching Rounds take approximately 20-25 minutes to complete. You must complete the Virtual Gallery and Case Simulation in order to be eligible to receive CME credit for this program.

This enduring material is presented in an online/computer-based format. There are no fees for participating and receiving CME credit for this activity. To receive CME/CE credit, please follow these steps:

1. Read the complete program information, learning objectives and faculty disclosures
2. Study the educational activity
3. Complete the online pre- and post-tests by selecting the best answer to each question
4. Complete the online evaluation form.

A statement of credit will be issued only upon completion of the entire activity and evaluation.

Your system must meet the following requirements:
Computer: with minimum processor and memory as recommended by operating system manufacturer.
Operating System: Windows: XP, Vista, 7. Macintosh OSX.
Internet Browser: Microsoft Internet Explorer 6, 7, 8 or later, Firefox 8.0 or later, Safari 5.1 or later, Google Chrome 16 or later.
Players & Plugins: Adobe Flash Player 9 or higher.
Audio: Functioning sound card with attached speakers installed.
Internet Connection: a broadband internet connection or wireless connection.

This activity is jointly sponsored by The Endocrine Society and Educational Awareness Solutions.
        


This activity is supported by educational grants provided by AbbVie Inc., Endo Pharmaceuticals Inc., and  Lilly USA, LLC
                

Ideal® • Copyright 2013